|
Outcome measures
|
Number of studies
|
Patients (HCR/CABG)
|
I2 (%)
|
Analysis model
|
Statistics method
|
OR/WMD
|
95% CI
|
p value
|
|---|
|
AF
|
5
|
468/1274
|
0
|
Fixed
|
M-H
|
0.93
|
0.70,1.23
|
0.60
|
|
Renal Failure
|
5
|
372/1191
|
0
|
Fixed
|
M-H
|
0.64
|
0.32,1.27
|
0.20
|
|
Intubation Time
|
3
|
132/160
|
93
|
Random
|
IV
|
−9.95
|
−18.58,-1.31
|
0.02
|
|
LOS in ICU
|
6
|
322/805
|
85
|
Random
|
IV
|
−17.47
|
−31.01,-3.93
|
0.01
|
|
LOS in hospital
|
5
|
304/775
|
82
|
Random
|
IV
|
−1.77
|
−3.07,-0.46
|
0.008
|
|
Red Blood Cells Transfusion
|
3
|
53/83
|
0
|
Fixed
|
IV
|
−1.25
|
−1.62,-0.88
|
P<0.00001
|
- OR odds ratio, WMD Weighted mean difference, M–H Mantel–Haenszel, IV inverse variance, CI confidence interval, AF atrial fibrillation, LOS in ICU lengths of stay in Intensive Care Unit, LOS in hospital lengths of stay in hospital.
